Overactive Bladder Syndrome
Pipeline by Development Stage
Competitive Landscape
10 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (10)
Total enrollment: 1,820 patients across 10 trials
A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder
Study of V117957 in Overactive Bladder Syndrome
Cycling Study With the Axonics System
Use of Repris Needle in Bladder Injection
Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol
OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.